Review of the Results of WT1 Peptide Vaccination Strategies for Myelodysplastic Syndromes and Acute Myeloid Leukemia from Nine Different Studies.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Review of the Results of WT1 Peptide Vaccination Strategies for Myelodysplastic Syndromes and Acute Myeloid Leukemia from Nine Different Studies.
- Published In:
- Frontiers in immunology, 6, 36 (2015)
- Authors:
- Di Stasi, Antonio, Jimenez, Antonio M, Minagawa, Kentaro, Al-Obaidi, Mustafa, Rezvani, Katayoun
- Database ID:
- RPEP-02614
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-02614APA
Di Stasi, Antonio; Jimenez, Antonio M; Minagawa, Kentaro; Al-Obaidi, Mustafa; Rezvani, Katayoun. (2015). Review of the Results of WT1 Peptide Vaccination Strategies for Myelodysplastic Syndromes and Acute Myeloid Leukemia from Nine Different Studies.. Frontiers in immunology, 6, 36. https://doi.org/10.3389/fimmu.2015.00036
MLA
Di Stasi, Antonio, et al. "Review of the Results of WT1 Peptide Vaccination Strategies for Myelodysplastic Syndromes and Acute Myeloid Leukemia from Nine Different Studies.." Frontiers in immunology, 2015. https://doi.org/10.3389/fimmu.2015.00036
RethinkPeptides
RethinkPeptides Research Database. "Review of the Results of WT1 Peptide Vaccination Strategies ..." RPEP-02614. Retrieved from https://rethinkpeptides.com/research/di-2015-review-of-the-results
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.